Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Neuro-Oncology|April 23, 2017
Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network studyCaroline Houillier, Hervé Ghesquières, Cécile Chabrot, et al.
Haematologica|December 10, 2020
Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical useAuriane Lesieur, Xavier Thomas, Olivier Nibourel, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2016
The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patientsLudovic Nguyen-Them, Myrto Costopoulos, Marie-Laure Tanguy, et al.
Blood|April 7, 2006
Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cellsMarion Gabillot-Carré, Yves Lepelletier, Martine Humbert, et al.
British Journal of Haematology|February 17, 2023
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective studySammara Chaubard, Amira Marouf, David Lavergne, et al.
The Lancet. Haematology|December 12, 2018
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational studyNicolas Delanoy, Jean-Marie Michot, Thibault Comont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2022
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life ExperienceVincent Marmouset, Justine Decroocq, Sylvain Garciaz, et al.
Blood|April 7, 2025
Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemiaSara K Silbert, Alexander W Rankin, Chloe N Hoang, et al.
Blood Advances|December 24, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Pageof 2